Criteo SA
For the period ended Dec 31, 2024. Filed Apr 29, 2025.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Dec 31, 2024 · Filed Apr 29, 2025
Use the contents to explore the available documents and sections.
Contents
Note
Note 18 – Other Current Assets
The following table shows the breakdown in other current assets net book value for the presented periods:
Annex C-50
| (In thousands of euros) | December 31, 2022 | December 31, 2023 | December 31, 2024 |
|---|---|---|---|
| Prepayments to suppliers | 11,646 | 6,786 | 10,585 |
| Employee-related receivables | 280 | 880 | 153 |
| Taxes receivables | 73,386 | 98,905 | 51,866 |
| Other debtors | 4,865 | 4,107 | 5,442 |
| Indemnification assets | 4,828 | 593 | — |
| Prepaid expenses | 24,994 | 23,973 | 18,747 |
| Derivatives | 2,038 | — | — |
| Gross book value at end of period | 122,037 | 135,244 | 86,793 |
| Net book value at end of period | 122,037 | 135,244 | 86,793 |
Prepaid expenses mainly consist of costs related to SaaS arrangements and licenses.
Note 19 – Cash and Cash Equivalents
Consolidated Statement of the Financial Position
The following table presents for each reported period, the breakdown of cash and cash equivalents:
| (In thousands of euros) | December 31, 2022 | December 31, 2023 | December 31, 2024 |
|---|---|---|---|
| Interest-bearing bank deposits | 61,793 | 45,995 | 37,772 |
| Cash & cash equivalents | 264,725 | 258,045 | 242,123 |
| Total Cash & cash equivalents | 326,518 | 304,040 | 279,895 |
The short-term investments included investments in money market funds and interest–bearing bank deposits which met IFRS 7 — Statement of Cash Flow criteria: short-term, highly liquid investments, for which the risks of changes in value are considered to be insignificant.
Interest-bearing bank deposits are considered level 2 financial instruments as they are measured using valuation techniques based on observable market data. For the cash and cash equivalents, the fair value approximates the carrying amount, given the nature of the cash and cash equivalents and the maturity of the expected cash flows.
Consolidated Statement of Cash Flow
The breakdown of cash & cash equivalents presented in the Consolidated Statement of Cash Flow can be reconciled with the financial statement position as follows:
| (In thousands of euros) | December 31, 2022 | December 31, 2023 | December 31, 2024 |
|---|---|---|---|
| Cash & cash equivalents | 326,518 | 304,040 | 279,895 |
| Net cash and cash equivalents | 326,518 | 304,040 | 279,895 |
Annex C-51
Note 20 – Common shares
The Group manages its capital to ensure that entities in the Company will be able to continue as a going concern while maximizing the return to shareholders through the optimization of the debt and equity balance.
Our capital structure consists of financial liabilities (net debt) and equity (issued capital, reserves, retained earnings and non-controlling interests).
The Group is not subject to any externally imposed capital requirements.
Change in Number of Shares
| Change in number of shares | Number of ordinary shares |
|---|---|
| Balance at January 1, 2023 | 57,263,624 |
| of which Common stock | 63,248,728 |
| of which Treasury stock | (5,985,104) |
| Issuance of shares under share option and free share plans (1) | (2,083,065) |
| Treasury shares issued for RSU vesting | 1,679,674 |
| Treasury shares issued for LUS vesting | 1,006,482 |
| Treasury shares retired | 2,185,000 |
| Share repurchase program (1) | (4,286,624) |
| Balance at December 31, 2023 | 55,765,091 |
| of which Common stock | 61,165,663 |
| of which Treasury stock | (5,400,572) |
| Issuance of shares under share option and free share plans (2) | (3,420,824) |
| Treasury shares issued for RSU vesting | 2,366,158 |
| Treasury shares issued for LUS vesting | 1,953,761 |
| Treasury shares retired | 3,590,000 |
| Share repurchase program (2) | (5,976,764) |
| Balance at December 31, 2024 | 54,277,422 |
| of which Common stock | 57,744,839 |
| of which Treasury stock | (3,467,417) |
(1) Approved by the Board of Directors on December 7, 2023
(2) Approved by the Board of Directors on April 25 and December 5, 2024
Annex C-52
Note 21 – Earnings Per Share
Basic Earnings Per Share
The Group calculates basic earnings per share by dividing the net income for the period attributable to shareholders of the Parent company by the weighted average number of shares outstanding.
| December 31, 2022 · December 31, 2023 · December 31, 2024 | ||||
|---|---|---|---|---|
| Net income attributable to shareholders of Criteo S.A. | 9,266 | 44,175 | 109,812 | |
| Weighted average number of shares outstanding | 60,004,707 | 56,170,658 | 54,817,136 | |
| Basic earnings per share | 0.15 | €0.79 | €2.00 | € |
Diluted Earnings Per Share
The Group calculates diluted earnings per share by dividing the net income attributable to shareholders of the Parent company by the weighted average number of shares outstanding plus any potentially dilutive shares not yet issued from share-based compensation plans (see note 8). There were no other potentially dilutive instruments outstanding as of December 31, 2022, 2023 and 2024. Consequently all potential dilutive effects from shares are considered.
For each period presented, a contract to issue a certain number of shares (i.e. share option, share warrant, restricted share award or BSPCE contracts) is assessed as potentially dilutive, if it is “in the money” (i.e., the exercise or settlement price is inferior to the average market price).
| December 31, 2022 · December 31, 2023 · December 31, 2024 | ||||
|---|---|---|---|---|
| Net income attributable to shareholders of Criteo S.A. | 9,266 | 44,175 | 109,812 | |
| Weighted average number of shares outstanding of Criteo S.A. | 60,004,707 | 56,170,658 | 54,817,136 | |
| Dilutive effect of : | 3,670,989 | 3,084,564 | 2,328,272 | |
| - Restricted share awards | 3,508,151 | 2,934,019 | 2,159,752 | |
| - Share options (OSA) and BSPCE | 98,432 | 98,384 | 113,656 | |
| - Share warrants | 64,406 | 52,161 | 54,864 | |
| Weighted average number of shares outstanding used to determine diluted earnings per share | 63,675,696 | 59,255,222 | 57,145,408 | |
| Diluted earnings per share | 0.15 | €0.75 | €1.92 | € |
Annex C-53
Note 22 – Employee Benefits
Defined Benefit Plans
According to the French law and the Syntec Collective Agreement, French employees are entitled to compensation paid on retirement.
The following table summarizes the changes in the projected benefit obligation:
| (In thousands of euros) | December 31, 2022 | December 31, 2023 | December 31, 2024 |
|---|---|---|---|
| Defined Benefit Obligation present value - Beginning of period | 5,037 | 3,633 | 3,739 |
| Service cost | 1,667 | 371 | 458 |
| Finance cost | 69 | 149 | 146 |
| Actuarial losses (gains) | (3,140) | (414) | 201 |
| Defined Benefit Obligation present value - End of period | 3,633 | 3,739 | 4,544 |
The Company does not hold any plan assets for any of the periods presented.
The reconciliation of the changes in the present value of projected benefit obligation with the Consolidated Statement of Income for the presented periods is illustrated in the following table:
| (In thousands of euros) | December 31, 2022 | December 31, 2023 | December 31, 2024 |
|---|---|---|---|
| Service cost | (1,667) | (371) | (458) |
| - Research and development expense | (846) | (243) | (305) |
| - Sales and operations expense | (322) | 45 | 29 |
| - General and administrative expense | (499) | (173) | (182) |
| Finance cost | (69) | (149) | (146) |
| - Finance income (expense) | (69) | (149) | (146) |
| Actuarial (losses) gains | 3,140 | 414 | (201) |
| - Other comprehensive (loss) income | 3,140 | 414 | (201) |
The main assumptions used for the purposes of the actuarial valuations are listed below:
| December 31, 2022 | December 31, 2023 | December 31, 2024 | |
|---|---|---|---|
| Discount rate (Corp AA) | 4.25% | 3.90% | 3.90% |
| Expected rate of salary increase | 5.00% | 6.96% | 6.96% |
| Expected rate of social charges | 48% | 48% | 49% |
| Estimated retirement age | Table progressive | Company based table | Company based table |
| Life table | TH-TF 2000-2002 shifted | TH-TF 2000-2002 shifted | TH-TF 2000-2002 shifted |
| Staff turnover assumptions | 0 - 17.8% | Company historical table | Company historical table |
Annex C-54
Defined Contribution Plans
The total expense represents contributions payable to these plans by us at specified rates.
In some countries, the Company’s employees are eligible for defined contribution post-retirement plans and similar financial benefits. Under defined contribution plans, the Company has no obligation other than to pay the agreed contributions, with the corresponding expense charged to income for the year. The defined contribution plans primarily related to France, the U.S., for 401(k) plans, and the United Kingdom.
| (In thousands of euros) | December 31, 2022 | December 31, 2023 | December 31, 2024 |
|---|---|---|---|
| Defined contributions plans included in personnel expenses | (16,253) | (16,598) | (17,616) |
Note 23 – Financial Liabilities
The changes in current and non-current financial liabilities during the periods ended December 31, 2024 are illustrated in the following schedules:
| (In thousands of euros) · December 31, 2023 · New borrowings · Repayments · Change in scope · Other · Currency translation adjustment · December 31, 2024 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Other financial liabilities | 70 | — | — | — | 216 | — | 286 | |
| Non current portion | 70 | — | — | — | 216 | — | 286 | |
| Borrowings (1) | — | — | — | — | — | — | — | |
| Other financial liabilities | 763 | 3 | (330) | — | (216) | (183) | 37 | |
| Derivatives | 2,304 | — | — | — | 639 | 2,943 | ||
| Current portion | 3,067 | 3 | (330) | — | 423 | (183) | 2,980 | |
| Borrowings (1) | — | — | — | — | — | — | — | |
| Other financial liabilities | 832 | 3 | (330) | — | — | (183) | 322 | |
| Derivatives | 2,304 | — | — | — | 639 | — | 2,943 | |
| Total | 3,136 | 3 | (330) | — | 639 | (183) | 3,266 | |
(1) includes accrued interest
Annex C-55
We are party to several loan agreements and revolving credit facilities, or RCF, with third-party financial institutions. Our loans and RCF agreements are presented in the table below:
| Date | Nominal/ Authorized amounts (in thousands of euros) | Amount drawn | Balance as of December 31, 2024 (in thousands of euros) | Interest rate | Settlement date |
|---|---|---|---|---|---|
| Bank syndicate RCF - Criteo SA | |||||
| September 1, 2022 | 407,000 | — | — | Floating rate : EURIBOR/SOFR + margin depending on leverage ratio | September 2027 |
| Other short-term lines of credit | |||||
| 21,500 | — | — | EURIBOR | ||
The Bank Syndicate Revolving Line of Credit is unsecured and contains customary events of default and covenants, including compliance with a total net debt to adjusted EBITDA ratio and restrictions on the incurrence of additional indebtedness. As of year-end December 31, 2024, and 2023, we were in compliance with the required covenants. On November 17, 2023, we updated certain terms of our €407.0 million syndicated credit facility to a €407.0 million sustainability-linked credit facility, the framework for which was provided for in the initial credit facility agreement. Certain terms and conditions of the amended credit facility are now linked to our sustainability goals to increase the representation of women in tech roles and reduce our GHG emissions, while the rest of the credit facility agreement remains unchanged.
As of December 31, 2024, and 2023, no amounts have been drawn or are outstanding under the revolving credit facility.
We are also party to short-term credit lines and overdraft facilities with HSBC plc, BNP Paribas and LCL with an authorization to draw up to a maximum of 21.5 million euros in the aggregate under the short-term credit lines and overdraft facilities. As of December 31, 2024, we had not drawn on any of these facilities. Any loans or overdrafts under these short-term facilities bear interest based on the one month EURIBOR rate or three month EURIBOR rate. As these facilities are exclusively short-term credit and overdraft facilities, our banks have the ability to terminate such facilities on short notice.
Annex C-56
Note 24 – Net debt
The company net debt is calculated by offsetting the cash and cash equivalents from the financial liabilities.
As shown in note 6 and 19, the market risk is monitored by management, who define the management policy regarding the consolidated net debt in terms of liquidity, interest rates, exchange rates and counterparty risk for the upcoming months and analyzes the previous events (realized transactions, financial results).
The following tables show the maturity and allocation by currency of our financial liabilities and cash and cash equivalents.
Net debt by maturity
| (In thousands of euros) · Carrying value · Maturity | ||||||
|---|---|---|---|---|---|---|
| 2025 · 2026 · 2027 · 2028 · 2029 | ||||||
| Other financial liabilities | 323 | 37 | 286 | — | — | — |
| Derivatives | 2,943 | 2,943 | — | — | — | — |
| Financial liabilities | 3,266 | 2,980 | 286 | — | — | — |
| Cash and cash equivalents | 279,895 | 279,895 | — | — | — | — |
| Net financial debt | (276,629) | (276,915) | 286 | — | — | — |
Net debt by currency
| (In thousands of euros) · Carrying value · Currency | ||||||
|---|---|---|---|---|---|---|
| EUR · GBP · USD · JPY · Others | ||||||
| Other financial liabilities | 323 | 307 | — | 16 | — | — |
| Derivatives | 2,943 | 2,943 | — | — | — | — |
| Financial liabilities | 3,266 | 3,250 | — | 16 | — | — |
| Cash and cash equivalents | 279,895 | 103,840 | 3,993 | 131,100 | 15,699 | 25,263 |
| Net financial debt | (276,629) | (100,590) | (3,993) | (131,084) | (15,699) | (25,263) |
Annex C-57
Note 25 – Contingencies
The change in contingencies is detailed in the following table:
| (In thousands of euros) · Provision for employee related litigation · Provisions for non income tax risks · Other provisions · Total | |||||||
|---|---|---|---|---|---|---|---|
| Balance at January 1, 2023 | 485 | 31,675 | 61,168 | 93,328 | |||
| Charges | 195 | — | 637 | 832 | |||
| Provision used | (30) | — | (40,000) | (40,030) | |||
| Provision released not used | (280) | (1,449) | (20,207) | (21,936) | |||
| Currency translation adjustments | — | (3) | (3) | ||||
| Other | — | (256) | (13) | (269) | |||
| Balance at December 31, 2023 | 370 | 29,970 | 1,582 | 31,922 | |||
| Charges | 723 | — | — | 723 | |||
| Provision used | (186) | — | — | (186) | |||
| Provision reversed not used (*) | (39) | — | (637) | (676) | |||
| Currency translation adjustments | (14) | — | 10 | (4) | |||
| Other | — | — | — | — | |||
| Balance at December 31, 2024 | 854 | 29,970 | 955 | 31,779 | |||
| of which current | 854 | — | 958 | 1,812 | |||
Legal and Regulatory Matters
Following a complaint from Privacy International against a number of advertising technology companies with certain data protection authorities, including in France, France's Commission Nationale de l'Informatique et des Libertés (the "CNIL") opened a formal investigation in January 2020 against Criteo. In June 2023, the CNIL issued its decision, which retained alleged European Union's General Data Protection Regulation ("GDPR") violations but reduced the financial sanction against Criteo from the original amount of €60 million ($64.2 million) to €40 million ($42.8 million). Criteo issued the required sanction payment during the third quarter of 2023. The decision relates to past matters and does not include any obligation for Criteo to change its current practices. Criteo has appealed this decision before the French Council of State (Conseil d’Etat).
We are party to a claim (Doe v. GoodRx Holdings, Inc. et al. in the U.S. District Court for the Northern District of California), alleging violations of various state and federal laws. We intend to vigorously defend our position, but we are unable to predict the potential outcome at this time.
Non income tax risks
We have recorded a 29.9 million euros provision related to certain non income tax items. These risks were identified and recognized as part of the Iponweb Acquisition in 2022.
Annex C-58
We have recorded an indemnification asset in the full amount of the provision as the Company is indemnified against certain tax liabilities under the purchase agreement for the Iponweb Acquisition. The indemnification asset is recorded as part of "Other noncurrent assets" on the consolidated statement of financial position.
Note 26 – Other current liabilities
Other current liabilities are presented in the following table:
| (In thousands of euros) | December 31, 2022 | December 31, 2023 | December 31, 2024 |
|---|---|---|---|
| Clients’ prepayments | 15,313 | 23,421 | 9,275 |
| Credit notes | 16,566 | 21,099 | 30,743 |
| Employee-related payables | 80,225 | 102,522 | 105,140 |
| Other taxes payables | 53,287 | 60,327 | 18,433 |
| Accounts payable relating to capital expenditures | 23,827 | 3,028 | 1,692 |
| Earn-out liability - current portion | 20,289 | 45,653 | 241 |
| Other creditors | 2,239 | 1,375 | 4,590 |
| Deferred revenue | 12 | 9 | 1,694 |
| Total | 211,758 | 257,434 | 171,808 |
Earn out liability
As part of the Iponweb Acquisition, the Sellers are entitled to contingent consideration of a maximum of €90.5 million ($100.0 million), which was subject to the achievement of certain revenue targets by the Iponweb business for the 2022 and 2023 fiscal years. The related earn out liability was fully settled during the year 2024.
Note 27 – Commitments and contingencies
Purchase Obligations
As of December 31, 2024, the Group had €73.8 million of other non-cancellable contractual obligations, primarily related to software licenses, maintenance and bandwidth for the servers.
Annex C-59
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.